Illumina Ventures raises $325M to fund health startups

By The Science Advisory Board staff writers

Illumina Ventures has raised $325 million for its second investment fund, which will support healthcare startups.

With the latest round of investments, Illumina Ventures has built up a genomic-focused fund of $560 million. The money will support early-stage companies that are developing life science tools, clinical diagnostics, and therapeutics platforms, as well as digital health and other genomics applications.

Illumina Ventures is an independently managed investment firm. Funding for the second fund is anchored by an investment from Illumina, with the rest committed by other strategic and financial advisors.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking